Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation

Chemoresistance blunts the efficacy of temozolomide (TMZ) in the treatment of glioblastoma (GBM). Elevated levels of O6-methylguanine-DNA methyltransferase (MGMT) and activation of signal transducer and of transcription 3 (STAT3) have been reported to correlate with GBM resistance to alkylator chemo...

Full description

Bibliographic Details
Main Authors: Moli Wu, Danyang Song, Hui Li, Nisar Ahmad, Hong Xu, Xiaobo Yang, Qian Wang, Xiaoxin Cheng, Sa Deng, Xiaohong Shu
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/11/9453
_version_ 1797597423143485440
author Moli Wu
Danyang Song
Hui Li
Nisar Ahmad
Hong Xu
Xiaobo Yang
Qian Wang
Xiaoxin Cheng
Sa Deng
Xiaohong Shu
author_facet Moli Wu
Danyang Song
Hui Li
Nisar Ahmad
Hong Xu
Xiaobo Yang
Qian Wang
Xiaoxin Cheng
Sa Deng
Xiaohong Shu
author_sort Moli Wu
collection DOAJ
description Chemoresistance blunts the efficacy of temozolomide (TMZ) in the treatment of glioblastoma (GBM). Elevated levels of O6-methylguanine-DNA methyltransferase (MGMT) and activation of signal transducer and of transcription 3 (STAT3) have been reported to correlate with GBM resistance to alkylator chemotherapy. Resveratrol (Res) inhibits tumor growth and improves drug chemosensitivity by targeting STAT3 signaling. Whether the combined therapy of TMZ and Res could enhance chemosensitivity against GBM cells and the underlying molecular mechanism remains to be determined. In this study, Res was found to effectively improve chemosensitivities of different GBM cells to TMZ, which was evaluated by CCK-8, flow cytometry, and cell migration assay. The combined use of Res and TMZ downregulated STAT3 activity and STAT3-regulated gene products, thus inhibited cell proliferation and migration, as well as induced apoptosis, accompanied by increased levels of its negative regulators: PIAS3, SHP1, SHP2, and SOCS3. More importantly, a combination therapy of Res and TMZ reversed TMZ resistance of LN428 cells, which could be related to decreased MGMT and STAT3 levels. Furthermore, the JAK2-specific inhibitor AG490 was used to demonstrate that a reduced MGMT level was mediated by STAT3 inactivation. Taken together, Res inhibited STAT3 signaling through modulation of PIAS3, SHP1, SHP2, and SOCS3, thereby attenuating tumor growth and increasing sensitivity to TMZ. Therefore, Res is an ideal candidate to be used in TMZ combined chemotherapy for GBM.
first_indexed 2024-03-11T03:05:52Z
format Article
id doaj.art-a2606252e3324cc2a81ce5523f0d98c0
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T03:05:52Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-a2606252e3324cc2a81ce5523f0d98c02023-11-18T07:59:14ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-05-012411945310.3390/ijms24119453Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 InactivationMoli Wu0Danyang Song1Hui Li2Nisar Ahmad3Hong Xu4Xiaobo Yang5Qian Wang6Xiaoxin Cheng7Sa Deng8Xiaohong Shu9College of Pharmacy, Dalian Medical University, Dalian 116044, ChinaCollege of Pharmacy, Dalian Medical University, Dalian 116044, ChinaCollege of Pharmacy, Dalian Medical University, Dalian 116044, ChinaCollege of Pharmacy, Dalian Medical University, Dalian 116044, ChinaCollege of Basic Medical Science, Dalian Medical University, Dalian 116044, ChinaCollege of Pharmacy, Dalian Medical University, Dalian 116044, ChinaCollege of Basic Medical Science, Dalian Medical University, Dalian 116044, ChinaCollege of Basic Medical Science, Dalian Medical University, Dalian 116044, ChinaCollege of Pharmacy, Dalian Medical University, Dalian 116044, ChinaCollege of Pharmacy, Dalian Medical University, Dalian 116044, ChinaChemoresistance blunts the efficacy of temozolomide (TMZ) in the treatment of glioblastoma (GBM). Elevated levels of O6-methylguanine-DNA methyltransferase (MGMT) and activation of signal transducer and of transcription 3 (STAT3) have been reported to correlate with GBM resistance to alkylator chemotherapy. Resveratrol (Res) inhibits tumor growth and improves drug chemosensitivity by targeting STAT3 signaling. Whether the combined therapy of TMZ and Res could enhance chemosensitivity against GBM cells and the underlying molecular mechanism remains to be determined. In this study, Res was found to effectively improve chemosensitivities of different GBM cells to TMZ, which was evaluated by CCK-8, flow cytometry, and cell migration assay. The combined use of Res and TMZ downregulated STAT3 activity and STAT3-regulated gene products, thus inhibited cell proliferation and migration, as well as induced apoptosis, accompanied by increased levels of its negative regulators: PIAS3, SHP1, SHP2, and SOCS3. More importantly, a combination therapy of Res and TMZ reversed TMZ resistance of LN428 cells, which could be related to decreased MGMT and STAT3 levels. Furthermore, the JAK2-specific inhibitor AG490 was used to demonstrate that a reduced MGMT level was mediated by STAT3 inactivation. Taken together, Res inhibited STAT3 signaling through modulation of PIAS3, SHP1, SHP2, and SOCS3, thereby attenuating tumor growth and increasing sensitivity to TMZ. Therefore, Res is an ideal candidate to be used in TMZ combined chemotherapy for GBM.https://www.mdpi.com/1422-0067/24/11/9453glioblastomaresveratroltemozolomideSTAT3STAT3 negative regulatorsMGMT
spellingShingle Moli Wu
Danyang Song
Hui Li
Nisar Ahmad
Hong Xu
Xiaobo Yang
Qian Wang
Xiaoxin Cheng
Sa Deng
Xiaohong Shu
Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation
International Journal of Molecular Sciences
glioblastoma
resveratrol
temozolomide
STAT3
STAT3 negative regulators
MGMT
title Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation
title_full Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation
title_fullStr Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation
title_full_unstemmed Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation
title_short Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation
title_sort resveratrol enhances temozolomide efficacy in glioblastoma cells through downregulated mgmt and negative regulators related stat3 inactivation
topic glioblastoma
resveratrol
temozolomide
STAT3
STAT3 negative regulators
MGMT
url https://www.mdpi.com/1422-0067/24/11/9453
work_keys_str_mv AT moliwu resveratrolenhancestemozolomideefficacyinglioblastomacellsthroughdownregulatedmgmtandnegativeregulatorsrelatedstat3inactivation
AT danyangsong resveratrolenhancestemozolomideefficacyinglioblastomacellsthroughdownregulatedmgmtandnegativeregulatorsrelatedstat3inactivation
AT huili resveratrolenhancestemozolomideefficacyinglioblastomacellsthroughdownregulatedmgmtandnegativeregulatorsrelatedstat3inactivation
AT nisarahmad resveratrolenhancestemozolomideefficacyinglioblastomacellsthroughdownregulatedmgmtandnegativeregulatorsrelatedstat3inactivation
AT hongxu resveratrolenhancestemozolomideefficacyinglioblastomacellsthroughdownregulatedmgmtandnegativeregulatorsrelatedstat3inactivation
AT xiaoboyang resveratrolenhancestemozolomideefficacyinglioblastomacellsthroughdownregulatedmgmtandnegativeregulatorsrelatedstat3inactivation
AT qianwang resveratrolenhancestemozolomideefficacyinglioblastomacellsthroughdownregulatedmgmtandnegativeregulatorsrelatedstat3inactivation
AT xiaoxincheng resveratrolenhancestemozolomideefficacyinglioblastomacellsthroughdownregulatedmgmtandnegativeregulatorsrelatedstat3inactivation
AT sadeng resveratrolenhancestemozolomideefficacyinglioblastomacellsthroughdownregulatedmgmtandnegativeregulatorsrelatedstat3inactivation
AT xiaohongshu resveratrolenhancestemozolomideefficacyinglioblastomacellsthroughdownregulatedmgmtandnegativeregulatorsrelatedstat3inactivation